Immune therapeutic strategies for the senescent tumor microenvironment

Area of Science:

• Oncology
• Immunology
• Cellular Biology

Background:

• Cellular senescence plays a dual role in cancer, potentially promoting an immunosuppressive tumor microenvironment (TME) or aiding immune surveillance.
• Despite advances in cancer immunotherapy, achieving durable responses in solid tumors, particularly advanced stages, remains a significant challenge.
• The senescent status within the TME is increasingly recognized for its impact on therapy resistance.

Purpose of the Study:

• To review recent advancements in targeting cellular senescence in cancer.
• To focus on immunomodulatory approaches to address the hallmarks of cellular senescence.
• To highlight strategies for overcoming therapy resistance associated with senescent cells.

Main Methods:

• Literature review of recent studies on cellular senescence and cancer immunotherapy.
• Analysis of immunomodulatory strategies targeting senescent cells.
• Synthesis of information on the role of senescence in the tumor microenvironment and therapy resistance.

Main Results:

• Cellular senescence presents complex interactions within the TME, affecting immunotherapy efficacy.
• Targeting senescent cells, particularly through immunomodulation, is a key area of research for enhancing treatment outcomes.
• Understanding the hallmarks of senescence is crucial for developing effective therapeutic strategies.

Conclusions:

• Cellular senescence is a critical factor influencing the success of cancer immunotherapy.
• Immunomodulatory targeting of senescent cells holds significant potential for improving durable responses in solid tumors.
• Further research into senolytics and immunomodulatory combinations is warranted to overcome treatment resistance.